Maurizio Sandrini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maurizio Sandrini has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Giovanni Vitale
Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy
8 shared publications - Luigi Alberto Pini
Inter Department Headache and Drug abuse Center, Modena University, Modena, Italy
7 shared publications - Patrizia Romualdi
Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, 40126, Bologna, Italy
2 shared publications A. Capobianco
Department of Pharmacology, University of Bologna, Bologna, Italy
1 shared publicationAnnalisa Capobianco
Department of Pharmacology, University of Bologna, Bologna, Italy
1 shared publicationG. Morelli
Department of Internal Medicine, Clinical Pharmacology Unit, University of Modena and Reggio Emilia, Modena, Italy
1 shared publication
Latest Publications
- Open Access
- 1 March 2007
- Published by Springer Nature in Inflammation Research
- Vol. 56 (4) , 139-142
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats
Objective and design: We investigated the antinociceptive effect of paracetamol or morphine after repeated administration and the changes in the characteristics of central μ-, κ- and 5-HT2 receptors. Treatment: Male rats were injected twice a day for seven days with paracetamol (400 mg/kg, i. p.) or morphine (5 mg/kg, s. c.). Methods: The antinociceptive effect was evaluated 30 min after single and multiple doses of paracetamol and morphine through the hot-plate test. Binding techniques were used to evaluate the receptor characteristics in the frontal cortex. Results: Both paracetamol and morphine induced an antinociceptive effect on day 1 but only paracetamol maintained this effect for seven days while morphine did not. The number of μ-opioid receptors decreased on days 1, 3, and 7 by a similar percentage after paracetamol administration (by 29, 31 and 34 %, respectively), while morphine produced a progressive decrease in comparison with controls (by 37, 49 and 60 %, respectively) and κ-opioid receptors were unaffected. Both drugs similarly decreased the 5-HT2 receptor number on all days of treatment (by about 30 %). Conclusions: The opioidergic and serotonergic systems are involved in different ways in the induction and maintenance of antinociception after paracetamol or morphine treatment.
- 1 March 2007
- Published by Springer Nature in Inflammation Research
- Vol. 56 (4) , 139-142
Open AccessEffect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats
Objective and design: We investigated the antinociceptive effect of paracetamol or morphine after repeated administration and the changes in the characteristics of central μ-, κ- and 5-HT2 receptors. Treatment: Male rats were injected twice a day for seven days with paracetamol (400 mg/kg, i. p.) or morphine (5 mg/kg, s. c.). Methods: The antinociceptive effect was evaluated 30 min after single and multiple doses of paracetamol and morphine through the hot-plate test. Binding techniques were used to evaluate the receptor characteristics in the frontal cortex. Results: Both paracetamol and morphine induced an antinociceptive effect on day 1 but only paracetamol maintained this effect for seven days while morphine did not. The number of μ-opioid receptors decreased on days 1, 3, and 7 by a similar percentage after paracetamol administration (by 29, 31 and 34 %, respectively), while morphine produced a progressive decrease in comparison with controls (by 37, 49 and 60 %, respectively) and κ-opioid receptors were unaffected. Both drugs similarly decreased the 5-HT2 receptor number on all days of treatment (by about 30 %). Conclusions: The opioidergic and serotonergic systems are involved in different ways in the induction and maintenance of antinociception after paracetamol or morphine treatment.
- 1 June 2005
- Published by Elsevier in Life Sciences
- Vol. 77 (20) , 2500-2513
Acute noise stress analgesia in relation to 5-HT2 and μ-opioid receptor changes in the frontal cortex of young mice
- 1 June 2005
- Published by Elsevier in Life Sciences
- Vol. 77 (20) , 2500-2513
Acute noise stress analgesia in relation to 5-HT2 and μ-opioid receptor changes in the frontal cortex of young mice
- Open Access
- 1 July 2003
- Published by Springer Nature in Inflammation Research
- Vol. 52 (8) , 347-352
Differential involvement of central 5-HT 1B and 5-HT 3 receptor subtypes in the antinociceptive effect of paracetamol
- 1 July 2003
- Published by Springer Nature in Inflammation Research
- Vol. 52 (8) , 347-352
Open AccessDifferential involvement of central 5-HT 1B and 5-HT 3 receptor subtypes in the antinociceptive effect of paracetamol
- 1 March 2002
- Published by Springer Nature in Inflammation Research
- Vol. 51 (3) , 154-159
Effect of rofecoxib on nociception and the serotonin system in the rat brain
Objective and design: The purpose of the present study was to determine whether the antinociceptive activity of rofecoxib is mediated, at least in part, through changes in the brain serotonergic system.¶Materials and subjects: Male Wistar rats weighing 180-200 g (groups of eight) were subjected to the hot-plate and formalin tests after rofecoxib treatment. Cortical areas were removed for serotonin (5-HT) level, 5-HT2 and μ-receptor evaluation.¶Treatment: Rofecoxib was administered orally at doses of 5, 10, 20 and 50 mg/kg for the time course evaluation in the hot-plate test (30, 60 and 120 min), and at the dose of 10 mg/kg for the formalin test and biochemical determinations.¶Methods: The tests performed were the hot-plate and the formalin assays. HPLC was used to determine 5-HT levels and radioligand-binding assays were utilized to evaluate the characteristics of 5-HT2 and μ-receptors. The data were analysed by ANOVA or Student's t test.¶Results: The lowest active dose of rofecoxib in the hot-plate test was 10 mg/kg. The percentage of the maximum possible effect (%MPE) values were: control = 1.7 ± 3.4; treated 23.4 ± 6.5 (p2 receptors. 5-HT levels (ng/g) were: control = 240.1 ± 28.5, rofecoxib = 326.1 ± 19.9 in the frontal cortex. The characteristics of μ-receptors did not change.¶Conclusions: These results suggest that rofecoxib may exert its therapeutic effect, at least in part, through the central serotonergic system. The opioidergic system, on the other hand, seems to be unaffected.
- 1 March 2002
- Published by Springer Nature in Inflammation Research
- Vol. 51 (3) , 154-159
Effect of rofecoxib on nociception and the serotonin system in the rat brain
Objective and design: The purpose of the present study was to determine whether the antinociceptive activity of rofecoxib is mediated, at least in part, through changes in the brain serotonergic system.¶Materials and subjects: Male Wistar rats weighing 180-200 g (groups of eight) were subjected to the hot-plate and formalin tests after rofecoxib treatment. Cortical areas were removed for serotonin (5-HT) level, 5-HT2 and μ-receptor evaluation.¶Treatment: Rofecoxib was administered orally at doses of 5, 10, 20 and 50 mg/kg for the time course evaluation in the hot-plate test (30, 60 and 120 min), and at the dose of 10 mg/kg for the formalin test and biochemical determinations.¶Methods: The tests performed were the hot-plate and the formalin assays. HPLC was used to determine 5-HT levels and radioligand-binding assays were utilized to evaluate the characteristics of 5-HT2 and μ-receptors. The data were analysed by ANOVA or Student's t test.¶Results: The lowest active dose of rofecoxib in the hot-plate test was 10 mg/kg. The percentage of the maximum possible effect (%MPE) values were: control = 1.7 ± 3.4; treated 23.4 ± 6.5 (p2 receptors. 5-HT levels (ng/g) were: control = 240.1 ± 28.5, rofecoxib = 326.1 ± 19.9 in the frontal cortex. The characteristics of μ-receptors did not change.¶Conclusions: These results suggest that rofecoxib may exert its therapeutic effect, at least in part, through the central serotonergic system. The opioidergic system, on the other hand, seems to be unaffected.
- 1 June 2001
- Published by Elsevier in Biochemical Pharmacology
- Vol. 61 (11) , 1409-1416
The effect of a paracetamol and morphine combination on dynorphin A levels in the rat brain44Abbreviations: NSAIDs, non-steroidal anti-inflammatory drugs; DYN, dynorphin; PARA, paracetamol; and ir-DYN, immunoreactive dynorphin.
- 1 June 2001
- Published by Elsevier in Biochemical Pharmacology
- Vol. 61 (11) , 1409-1416
The effect of a paracetamol and morphine combination on dynorphin A levels in the rat brain44Abbreviations: NSAIDs, non-steroidal anti-inflammatory drugs; DYN, dynorphin; PARA, paracetamol; and ir-DYN, immunoreactive dynorphin.
- 1 April 2001
- Published by Elsevier in Neuropeptides
- Vol. 35 (2) , 110-116
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain
- 1 April 2001
- Published by Elsevier in Neuropeptides
- Vol. 35 (2) , 110-116
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain
- 1 January 1995
- Vol. 21 (5) , 181-6
Lack of activity of azapropazone in the hot-plate test and in 5-HT1A and 5-HT2 receptor subtypes in rat brain membranes.
This study aimed to investigate the antinociceptive activity of azapropazone (AZA), a weak prostaglandin synthesis inhibitor using the hot-plate test, and its ability to modify the serotonin-binding capacity in rat brain membranes. It revealed that AZA had no antinociceptive effect in the hot-plate test at the doses of 400 and 600 mg/kg when orally administered (p.o.), and at 400, 500 and 600 mg/kg after intraperitoneal injection (i.p.). At the dose of 600 mg/kg i.p. the drug failed to modify the number and the affinity of 5-HT1A and 5-HT2 receptors in rat brain membranes. In accordance with our previous findings on a positive correlation between NSAIDs antinociception in this experimental model and changes in 5-HT receptor characteristics, these results suggest an association between the lack of AZA-mediated antinociception in the hot-plate test and the drug's inability to modify the characteristics of 5-HT1A and 5-HT2 receptor binding sites in rat brain membranes.
- 1 January 1995
- Vol. 21 (5) , 181-6
Lack of activity of azapropazone in the hot-plate test and in 5-HT1A and 5-HT2 receptor subtypes in rat brain membranes.
This study aimed to investigate the antinociceptive activity of azapropazone (AZA), a weak prostaglandin synthesis inhibitor using the hot-plate test, and its ability to modify the serotonin-binding capacity in rat brain membranes. It revealed that AZA had no antinociceptive effect in the hot-plate test at the doses of 400 and 600 mg/kg when orally administered (p.o.), and at 400, 500 and 600 mg/kg after intraperitoneal injection (i.p.). At the dose of 600 mg/kg i.p. the drug failed to modify the number and the affinity of 5-HT1A and 5-HT2 receptors in rat brain membranes. In accordance with our previous findings on a positive correlation between NSAIDs antinociception in this experimental model and changes in 5-HT receptor characteristics, these results suggest an association between the lack of AZA-mediated antinociception in the hot-plate test and the drug's inability to modify the characteristics of 5-HT1A and 5-HT2 receptor binding sites in rat brain membranes.
- 1 January 1993
- Vol. 19 (1) , 13-8
The role of serotonin brain receptors in the analgesic effect of phenazone.
The effects of treatment with para-chloro-phenyl-alanine (PCPA) (100 mg/kg i.p. for 4 days) were studied on the hot-plate test and on brain 5-HT binding in phenazone treated rats. Phenazone per se induces analgesia in the hot-plate test and decreases the number of cortical and pontine 5-HT binding sites A pre-treatment with PCPA prevents both the analgesic effect and the reduction of 5-HT binding sites caused by phenazone. These data suggest that the brain serotonin system may play a role in phenazone-induced antinociception.
- 1 January 1993
- Vol. 19 (1) , 13-8
The role of serotonin brain receptors in the analgesic effect of phenazone.
The effects of treatment with para-chloro-phenyl-alanine (PCPA) (100 mg/kg i.p. for 4 days) were studied on the hot-plate test and on brain 5-HT binding in phenazone treated rats. Phenazone per se induces analgesia in the hot-plate test and decreases the number of cortical and pontine 5-HT binding sites A pre-treatment with PCPA prevents both the analgesic effect and the reduction of 5-HT binding sites caused by phenazone. These data suggest that the brain serotonin system may play a role in phenazone-induced antinociception.